FRATAGENE
  • Friedreich Ataxia
  • Programs
    • Drug discovery programs
    • Drug repositioning programs
  • Company
    • Team
    • Scientific advisory board
  • News
  • Contacts

TEAM

64x64

Alessandra Rufini, Ph.D.

Scientific Director. Senior Scientist at the LABST, Department of Biomedicine and Prevention, Rare Diseases Section, University of Rome "Tor Vergata".

Linkedin
64x64

Roberto Testi, M.D.

Founder and President. Director of the LABST, Department of Biomedicine and Prevention, Head of Rare Diseases Section, University of Rome "Tor Vergata". Full Professor and Chairman of Immunology, School of Medicine, University of Rome "Tor Vergata".

Linkedin

PARTNERS

64x64

CureFA Foundation

The CureFA Foundation, Rye, N.Y., USA, funds scientific projects and industry partnerships that leverage new technologies for the treatment and cure of Friedreich's Ataxia.

  • LABST
  • Twitter
  • Linkedin

COPYRIGHT FRATAGENE 2018